Medical Developments (MVP.AX)
PRICE RANGE CHANGE
Trading: BUY @ $3.96
Signal Strength: WEAK
Indicator MUST BE USED in additional to another technical indicator to confirmation for trading entry. Indicator can be applied to the short term timeframe but is only able to give and indication of the strength of the buyers versus sellers at the market close. This bar analysis can provide guidance on the daily battle between sellers and buyers from the companies recent trading.
Medical Developments (ASX:MVP) buyers are in control at the market close. This is the first day of buyer commitment for Medical Developments adding strength to an uptrend in the first timeframe & highlights the commitment of buyers to carry positions overnight. Over the last 12 months there has been 3 trading days with the closing price in the upper part of the range giving a confirmation ratio of 1.1%. Over the last month there has been 3 trading days with the closing price in the upper range giving a confirmation ratio of 21.4%. Currently this quarter, closing price has spent 3 days in the upper price range compared to 2 days in the lower range giving a ratio of 1.5x.
Where the closing price fall within the day’s trading range highlights whether are in control.
[Calculations] Close Today Versus Range Today (CTRT):
1) When the closing price is near the high of the day buyers were in control at the close of the trading session;
2) When the closing price is near the low of the day sellers were in control at the close of the trading session;
3) When the closing price is near the middle of the day’s range where neither the buyers or sellers were in control at the close of the trading session;
PROFILE: Medical Developments (MVP.AX)
Stock Exchange: ASX
Company: Medical Developments
Ticker Codes: | MVP.AX | ASX:MVP |
Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment. The company operates in three segments: Pharmaceuticals, Medical Devices, and Veterinary products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management; Penthrox, a prescription only medicine for acute pain; medical devices; and various veterinary anesthetic machines to veterinarians. The company operates in Australia, Europe, North America, the Middle East, Asia, and South Africa. Medical Developments International Limited is headquartered in Scoresby, Australia.
Close vs RangeDownload
|LOV Lovisa||9.3||20.2||1,518,896||-1||BEARISH CROSSOVER|
|ORE Orocobre||3.2||7.4||2,255,245||-1||BEARISH CROSSOVER|
|SXY Senex Energy||0.38||7.1||10,983,458||-1||BEARISH CROSSOVER|
|AYS Amaysim Australia||0.95||5.6||94,182||-1||BEARISH CROSSOVER|
|FWD Fleetwood||1.8||5.6||420,408||-1||BEARISH CROSSOVER|
|CLQ Clean Teq Holdings||0.33||4.8||1,404,811||-1||BEARISH CROSSOVER|
|SGM Sims||11.66||4.7||1,667,336||-1||BEARISH CROSSOVER|
|PNR Pacific Niugini Minerals||0.25||4.2||1,178,071||-1||BEARISH CROSSOVER|
|WAF West African Resources||0.27||3.9||2,108,072||-1||BEARISH CROSSOVER|
|SBM St Barbara Mines||5.24||2.9||3,957,141||-1||BEARISH CROSSOVER|